PROGYNY INC
PGNYNASDAQTrading Snapshot
- Day Range
- $26.38 – $26.77
- 52-Week Range
- $16.10 – $30.10
- Volume
- $2.59B
- Avg Volume
- $3.22B
- Shares Outstanding
- 78.3M
- Next Earnings
- Sep 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.30B
- Last Q Revenue
- $297M
- P/E Ratio
- 34.9
- P/S Ratio
- 1.8x
- EPS (TTM)
- $0.77
- Dividend Yield
- —
Why Investors Own PGNY
- ✓High-growth profile — revenue up -7.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 76% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PROGYNY INC
A company profile for PROGYNY INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out
Progyny, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-07. The following slide deck was published by Progyny, Inc.
Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2026 Earnings Call August 6, 2026 4:45 PM EDTCompany ParticipantsJames Hart - Vice President of Investor RelationsPeter Anevski -...
Progyny (NASDAQ:PGNY) Shares Slide After Q2 Beat Overshadowed by Weak Guidance
Progyny (PGNY) reported mixed Q2 results: adjusted EPS beat, revenue in line. But weaker Q3 and FY guidance triggered a 15.6% aftermarket selloff.
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out
Progyny Sees Q3 GAAP EPS $0.30-$0.33 vs $0.34 Est
Progyny (NASDAQ:PGNY) is looking for Q3 GAAP EPS of $0.30-$0.33 vs $0.34 analyst estimate..